The quality of evidence for the FDA’s emergency use authorization (EUA) of COVID-19 vaccines for children as young as 6 months is drawing scrutiny from high-profile doctors and academics, some of whom are asking the White House not to pressure parents to vaccinate.
With CDC seroprevalence data from February finding 75% of minors had natural immunity, more attention is going to the risk/benefit calculation of vaccines for the age group at lowest risk from COVID.
Read the full story